Dr. Elmacken is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 718-334-3380- Is this information wrong?
Education & Training
- Westchester Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- University of Alexandria Faculty of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 2012 - 2024
- NY State Medical License 2012 - 2024
- MD State Medical License 2017 - 2024
- MI State Medical License 2018 - 2022
- DC State Medical License 2015 - 2018
- NH State Medical License 2012 - 2014
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.Mona Elmacken, Helkha Peredo-Pinto, Cong Wang, Zhenzhen Xu, Million Tegenge, Adnan A Jaigirdar, Marc R Theoret, Tejashri Purohit-Sheth, Yvette L Kasamon> ;Clinical Cancer Research. 2024 Jun 3
- 68 citationsObinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituxima...Aradhana Awasthi, Janet Ayello, Carmella van de Ven, Mona Elmacken, Anthony Sabulski, Matthew J. Barth, Myron S. Czuczman, Humayun Islam, Christian Klein, Mitchell S. ...> ;British Journal of Haematology. 2015 Oct 16
Hospital Affiliations
- DMC Children's Hospital of MichiganDetroit, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: